Oxford MEStar

Oxford MEStar specializes in translational and regenerative medicine, focusing on the development of innovative technologies and bioengineering solutions. The company provides products and services aimed at enhancing the capabilities of the translational and regenerative medicine industry, particularly in the areas of stem cell processing, engineered tissue manufacturing, and cellular bioproducts. With expertise in bioprocessing and bio-manufacturing, Oxford MEStar enables clients to access advanced techniques such as 3D bioprinting and in-vitro diagnostics. Additionally, the company facilitates technology transfer between the UK and China, enhancing international collaboration in the field.

Simon Bayly Ph.D

COO

1 past transactions

Mode Diagnostics

Acquisition in 2016
Mode Diagnostics is exploiting the electrochemical properties of biomarkers to produce novel assays for home diagnostic purposes. The company has developed a suite of technologies comprising assay development techniques, biosensing capabilities, microfabrication, electronics and wireless communications. MODE is an innovative product development company rapidly building a pipeline of user friendly and medically informative health screening products specifically designed for the Physicians office and consumer self-testing. MODE’s proprietary platform – measure – is a flexible, low-cost and hygenic platform that can easily be configured to create health tests for both the Physicians Office and Consumer self-testing. MODE’s first product, measure BOWEL HEALTH represents an evolution in bowel cancer screening (faceal occult blood) offering significant improvements over the current testing methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.